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Introduction 
 
Multiple sclerosis (MS) is a complex autoimmune disease with inflammation and demyelination 
within of the central nervous system (CNS). Histamine and its receptors have been implicated in 
MS disease pathogenesis. Histamine is an ubiquitous inflammatory mediator of numerous 
physiological processes including local immune responses and allergic reactions, and it plays an 
important role in neurotransmission. The functions of histamine are mediated through 4 G-protein 
coupled receptors (H1-H4 receptors). Histamine and histamine receptors play a regulatory role in 
experimental allergic encephalomyelitis (EAE), the animal model of MS [1-3]. Rodent 
experiments revealed that histamine increases the permeability of the blood brain barrier, 
promoting CNS inflammation [3-5]. The cytokine granulocyte-macrophage colony-stimulating 
factor (GM-CSF) in auto-reactive T helper cells is mandatory to induce and sustain EAE in mice 
[6]. GM-CSF stimulates granulocytes and macrophages, and both secrete histamine. A small study 
by Tuomisto et al., 1983 [7] reported on higher CSF histamine level by about 60% both in patients 
with remitting and progressive type of MS than in controls. Based on this observation and 
previous studies in EAE, we hypothesized that histamine might play a role in MS. Thus, we aimed 
at testing whether histamine is elevated in the CSF of MS patients.  
 
Methods 
We prospectively enrolled consecutive MS patients of Caucasian origin treated in the MS center 
of the University Hospital Zurich and age and gender-matched healthy volunteers. In all patients, 
the diagnosis of MS was made according to the current criteria. We enrolled all types of MS. In all 
patients, a diagnostic lumbar puncture was performed. In the controls, cerebrospinal fluid (CSF) 
was ascertained during spinal anesthesia. Subjects with signs of neurological or sleep-wake 
disorders were not included as controls. All patients and healthy controls gave informed written 
consent. This study was approved by the local ethics committee.  
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After assessment of CSF, samples were immediately put on dry ice and stored at -80°C. Samples 
were separated by high-performance liquid chromatography (HPLC), thereafter histamine was 
post-labeled by O-phthalaldehyde and detected by fluorometric analysis. [8] HPLC has been used 
for the measurement of histamine in CSF in other neurological disorders. [9] 
Statistical analyses were performed with SPSS 19.0. Group data are described by means and 
standard deviations (SD). For the comparison of parametric data, we Student’s t-tests, and for non-
parametric data, Whitney U-test was used. For correlation analyses in parametric data, we used a 
two way Pearson analysis. To control for effects of sex, age and different types of MS on 
histamine concentrations, we ran multivariate nominal regression analyses.  
 
Results 
We included 36 MS patients (51±10 years; 64% female; 24 patients with secondary progressive 
disease, 12 relapsing-remitting) and 19 healthy volunteers (46±10 years, 37% female). CSF 
histamine levels in patient samples were significantly higher (36.5±30.8 pg/ml) than in controls 
(12.0±18.6; Wald=5.7; p=0.017). In addition, histamine increased with age (Pearson's correlation, 
p=0.003), but were similar men (30.0 ± 27.0) and women (39.2 ± 6.4; t = 0.89; p = 0.381) and 
were not associated with diagnosis of relapsing remitting (26.0 ± 28.2) versus secondary 
progressive MS (39.9 ± 31.6; t = 1.5; p = 0.154). 
Discussion 
This study confirmed results by Tuomisto et al. [7] and our hypothesis that histamine levels are 
increased in MS patients The GM-CSF mediated stimulation of granulocytes and macrophages 
may be one possible underlying mechanism. Thus histamine may be an important factor for both 
the initiation and maintenance of chronic inflammatory diseases of the central nervous system 
such as multiple sclerosis (MS). Our results are limited by the small study size and the large intra-
group variability of histamine levels. However, this observation encourages a deeper investigation 
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of the role of GM-CSF, granulocytes, macrophages and histamine in MS. Further, histamine may 
be investigated as diagnostic marker for MS and other inflammatory CNS diseases.  
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Figure 1 
 
Cerebrospinal fluid histamine levels in 36 patients with multiple sclerosis and in 19 healthy 
controls. Each dot represents one patient, and horizontal lines depict mean levels per group. 
 
 
